header-component

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Products

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

Support

About Us

Blogs

Press Center

Events

News

Careers

Partnerships

Contact Us

Our Company

footer-menu-component

container

footer-social-menu-component

secondary-account-menu

secondary-primary-menu

products

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

zone1

footer-legal-menu

Terms of use

Privacy

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

cengage:galethorndikeseo

footer

Request a Trial

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

mega-menu

Account Information

bundle-connector

footer-legal-menu-component

footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

secondary-storefront-menu

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

zone3

header

config

gale-footer

zone2

FIND YOUR REP

support-order-2

single-column

Profile

Orders

Wish List

Fast Order Entry

My Account

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

Browse by Institution Type

Browse by Product Type

Diseases & Conditions

Health, Medicine & Nursing

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

<P>This text is designed for researchers and clinicians involved in urologic practice, including urologists, medical oncologists, pathologists and radiologists. It provides comprehensive guidance for treating and understanding bladder cancer and serves as an up-to-date reference reflecting evidence-based research. The biological behavior of this disease entity shows a heterogeneous pattern with diverse morbidity and mortality depending on a variety of factors, such as tumor characteristics (tumor stage, grade, size, number, shape, and histologic subtypes) and applied treatment modalities (surgery or non-surgical management).</P>

Bladder Cancer

COLFR

COLSO

COLJR

COLSR

BLADDER CANCER

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Contents.
List of Contributors.
About the Editor.
Preface.
Epidemiology, Etiology, and Pathophysiology.
1: Epidemiology.
2: Etiology (Risk Factors for Bladder Cancer).
3: Pathophysiology of Bladder Cancer.
Diagnosis.
4: Symptoms.
5: Physical Examination.
6: Urine Cytology and Urinary Biomarkers.
7: Cystoscopy.
8: Bladder Cancer: Imaging.
9: Transurethral Resection of Bladder Tumors.
10: Recent Technological Advances in Cystoscopy for the Detection of Bladder Cancer.
Pathology and Staging.
11: Histological Classification of Bladder Tumors.
12: Tumor, Nodes, Metastases (TNM) Classification System for Bladder Cancer.
Treatment for Nonmuscle Invasive Bladder Cancer (NMIBC).
13: Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer.
14: Treatment for TaT1 Tumors.
15: Treatment for Carcinoma In Situ.
16: Treatment for T1G3 Tumor.
17: Single, Immediate, Postoperative Intravesical Chemotherapy.
18: Second Transurethral Resection of Bladder Cancer.
19: Intravesical Chemotherapy.
20: Immunotherapy: Bacille Calmette&#x2013;Gu&#x00E9;rin.
21: Treatment of Failure of Intravesical Therapy.
Treatment for Muscle-Invasive Bladder Cancer (MIBC).
22: Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
23: Radical Cystectomy (RC) with Urinary Diversion.
24: Open Techniques and Extent (Including Pelvic Lymphadenectomy).
25: Morbidity, Mortality, and Survival for Radical Cystectomy.
26: Adjuvant Chemotherapy.
27: Bladder-Sparing Treatments.
28: Quality of Life in Bladder Cancer Patients.
Chemotherapy for Metastatic Bladder Cancer.
Follow-Up (Surveillance).
29: Surveillance for Non-Muscle-Invasive Bladder Cancer.
30: The Surveillance for Muscle-Invasive Bladder Cancer (MIBC).
31: Novel and Emerging Surveillance Markers for Bladder Cancer.
Future Perspective in Bladder Cancer.
32: Microbiome.
33: Genetic Testing, Genetic Variation, and Genetic Susceptibility.
34: CRISPR-Genome Editing.
35: Personalized Medicine.
Index.

Bladder Cancer.css-1p8rvzy{position:absolute;padding-left:8px;}

Bladder Cancer